advertisement
Molecular Therapy 25
Showing records 1 to 25 | Display all abstracts in Molecular Therapy79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Chitranshi N
Molecular Therapy 2019; 27: 424-441
78810 Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery
Fernando O
Molecular Therapy 2018; 26: 2812-2822
78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Bosco A; Anderson SR
Molecular Therapy 2018; 26: 2379-2396
78810 Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery
Tagalakis AD
Molecular Therapy 2018; 26: 2812-2822
79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Dheer Y
Molecular Therapy 2019; 27: 424-441
78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Breen KT
Molecular Therapy 2018; 26: 2379-2396
78810 Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery
Awwad S
Molecular Therapy 2018; 26: 2812-2822
79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Mirzaei M
Molecular Therapy 2019; 27: 424-441
78810 Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery
Brocchini S
Molecular Therapy 2018; 26: 2812-2822
78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Romero CO
Molecular Therapy 2018; 26: 2379-2396
79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Wu Y
Molecular Therapy 2019; 27: 424-441
78810 Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery
Khaw PT
Molecular Therapy 2018; 26: 2812-2822
78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Steele MR
Molecular Therapy 2018; 26: 2379-2396
79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Salekdeh GH
Molecular Therapy 2019; 27: 424-441
78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Chiodo VA
Molecular Therapy 2018; 26: 2379-2396
79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Abbasi M
Molecular Therapy 2019; 27: 424-441
78810 Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery
Hart SL
Molecular Therapy 2018; 26: 2812-2822
78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Boye SL
Molecular Therapy 2018; 26: 2379-2396
78810 Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery
Yu-Wai-Man C
Molecular Therapy 2018; 26: 2812-2822
78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Hauswirth WW
Molecular Therapy 2018; 26: 2379-2396
79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Vander Wall R; You Y
Molecular Therapy 2019; 27: 424-441
78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Tomlinson S
Molecular Therapy 2018; 26: 2379-2396
79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Graham SL
Molecular Therapy 2019; 27: 424-441
78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Vetter ML
Molecular Therapy 2018; 26: 2379-2396
79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Gupta V
Molecular Therapy 2019; 27: 424-441